Genetically encoded, metabolically autonomous production of site-specifically clickable lantibiotics via methionine analog incorporation in bacteria
| dc.contributor.author | Mander, Harjasmin | |
| dc.contributor.examiningcommittee | Davis, Rebecca (Chemistry) | |
| dc.contributor.examiningcommittee | Stefeld, Jörg (Chemistry) | |
| dc.contributor.examiningcommittee | Chelikani, Prashen (Oral Biology) | |
| dc.contributor.examiningcommittee | Vederas, John (University of Alberta) | |
| dc.contributor.supervisor | Budisa, Nediljko | |
| dc.contributor.supervisor | Sorensen, John | |
| dc.date.accessioned | 2026-10-30T16:06:53Z | |
| dc.date.available | 2026-10-30T16:06:53Z | |
| dc.date.issued | 2026-09-23 | |
| dc.date.submitted | 2026-09-23T23:17:30Z | en_US |
| dc.date.submitted | 2026-10-29T01:11:34Z | en_US |
| dc.degree.discipline | Chemistry | |
| dc.degree.level | Doctor of Philosophy (Ph.D.) | |
| dc.description.abstract | This thesis demonstrates that the successful incorporation of non-canonical amino acids into functional proteins is not determined solely by the chemistry of the amino acid analog, but by a coordinated interplay between chemical compatibility, enzymatic specificity, and cellular context. Using EGFP as a controlled model system, we show that methionine analog incorporation follows predictable principles based on side-chain polarity and local structural environment, establishing a framework for compatibility between non-canonical residues and protein function. Extending these principles to a complex, post-translationally modified system, we engineered a fully functional E. coli-based production platform for the lantibiotic Nisin, enabling site-specific incorporation of clickable methionine analogs. Through metabolic engineering, including MetRS overexpression and genomic integration of azidohomoalanine biosynthesis pathways, we transitioned from external supplementation to an autonomous, genetically encoded system for non-canonical amino acid production and incorporation. This system retains antimicrobial activity while introducing chemical functionality for downstream modification. Together, these results establish that non-canonical amino acid incorporation is a systems-level problem governed by the balance between translational machinery, metabolic flux, and protein-specific structural tolerance. This work provides both a mechanistic framework for predicting successful incorporation and a scalable platform to produce chemically programmable therapeutic peptides. | |
| dc.description.note | February 2027 | |
| dc.identifier.uri | http://hdl.handle.net/1993/40196 | |
| dc.language.iso | eng | |
| dc.subject | Synthetic Biology | |
| dc.subject | Lanthibiotics | |
| dc.subject | Nisin A | |
| dc.subject | Antimicrobial Resistance | |
| dc.title | Genetically encoded, metabolically autonomous production of site-specifically clickable lantibiotics via methionine analog incorporation in bacteria | |
| local.subject.manitoba | no |